ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Corporate Action, English, IR, Issuance, MAR, News, Regulatory, Shares
November 18, 2024
25 Sep 2019

Acarix carries out a rights issue of approximately SEK 51.8 million to finance an increased market expansion

Press release  Malmö, 25 September 2019Acarix carries out a rights issue of approximately SEK 51.8 million to finance an incr...
Continue reading
author-avatar acarix
Interim, IR, MAR, News, Q2, Regulatory, Report, Swedish
November 18, 2024
06 Aug 2019

Acarix AB (publ) publicerar delårsrapport, januari – juni 2019

Acarix AB (publ) publicerar delårsrapport, januari – juni 2019Malmö den 6 augusti 2019CADScor®System inkluderad i ...
Continue reading
author-avatar acarix
English, Interim, IR, MAR, News, Q2, Regulatory, Report
November 18, 2024
06 Aug 2019

Acarix AB (publ) publishes Interim Report, January – June 2019

Acarix AB (publ) publishes Interim Report, January – June 2019Malmö, August 6, 2019CADScor®System Included in UK guidanc...
Continue reading
author-avatar acarix
English, Interim, IR, MAR, News, Q1, Regulatory, Report
November 18, 2024
16 May 2019

“CADScor®System will shorten waiting lists and add value for both patients and healthcare system” Dr. Werner Kommer Facharzt für Innere Medizin und Kardiologie in Wolkersdorf, Austria

Interim Report, January – March 2019Malmö, May 16, 2019“CADScor®System will shorten waiting lists and add value fo...
Continue reading
author-avatar acarix
Interim, IR, MAR, News, Q1, Regulatory, Report, Swedish
November 18, 2024
16 May 2019

”CADScor®Systemet kommer att förkorta väntelistor och generera mervärde för både patienter och vårdsektorn” Dr. Werner Kommer Facharzt für Innere Medizin und Kardiologie in Wolkersdorf, Austria

Delårsrapport januari-mars 2019Malmö den 1 maj 2019”CADScor®Systemet kommer att förkorta väntelistor och...
Continue reading
author-avatar acarix
Annual, English, IR, MAR, News, Regulatory, Report
November 18, 2024
25 Apr 2019

Acarix publishes the annual report for 2018

Press release Malmö, April 25, 2019Acarix publishes the annual report for 2018Today, Thursday April 25, Acarix is publishing its A...
Continue reading
author-avatar acarix
Annual, IR, MAR, News, Regulatory, Report, Swedish
November 18, 2024
25 Apr 2019

Acarix publicerar årsredovisningen för 2018

Press release Malmö, 25 april, 2019Acarix publicerar årsredovisningen för 2018Idag, torsdagen den 25 april, publicerar ...
Continue reading
author-avatar acarix
Interim, IR, MAR, News, Regulatory, Report, Swedish, Yearend
November 18, 2024
20 Feb 2019

Acarix Bokslutskommuniké 2018: Marknadsdynamiken är gynnsam för CADScor®System med förmåga att påverka utmaningarna på den globala sjukvårdsmarknaden

Malmö den 20 februari 2019Acarix Bokslutskommuniké 2018: Marknadsdynamiken är gynnsam för CADScor®System med ...
Continue reading
author-avatar acarix
English, Interim, IR, MAR, News, Regulatory, Report, Yearend
November 18, 2024
20 Feb 2019

Acarix Year-End Report 2018: Market dynamics favourable for CADScor®System, addressing the challenges of the global healthcare market

Malmö, February 20, 2019Acarix Year-End Report 2018: Market dynamics favourable for CADScor®System, addressing the challenges ...
Continue reading
author-avatar acarix
Corporate Information, IR, MAR, News, Other Corporate Information, Regulatory, Swedish
November 18, 2024
15 Feb 2019

Acarix anpassar processen för tysk ersättning – Lämnar in ny dokumentation i slutet av februari 2019

Press release Malmö, 15 februari, 2019Acarix anpassar processen för tysk ersättning- Lämnar in ny dokumentation i s...
Continue reading
author-avatar acarix
Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory
November 18, 2024
15 Feb 2019

Acarix adapts pathway for German reimbursement – Submission of new dossier by the end of February 2019

Press release Malmö, February 15, 2019Acarix adapts pathway for German reimbursement- Submission of new dossier by the end of Febr...
Continue reading
author-avatar acarix
Interim, IR, MAR, News, Q3, Regulatory, Report, Swedish
November 18, 2024
14 Nov 2018

Kundutvärdering av CADScor®System ger positivt resultat jämfört med befintliga metoder

Delårsrapport januari-september 2018Malmö den 14 november 2018Kundutvärdering av CADScor®System gerpositivt resulta...
Continue reading
  • «
  • ‹
  • 4
  • 5
  • 6
  • 7
  • 8
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.